Jill DeSimone's most recent trade in Praxis Precision Medicines Inc was a trade of 8,566 Common Stock done at an average price of $44.3 . Disclosure was reported to the exchange on June 24, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.25 per share. | 24 Jun 2026 | 8,566 | 10,903 | - | 44.3 | 379,046 | Common Stock |
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2026 | 8,566 | 0 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2026 | 3,034 | 0 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 147.30 per share. | 24 Jun 2026 | 3,034 | 13,937 | - | 147.3 | 446,908 | Common Stock |
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Sale of securities on an exchange or to another person at price $ 311.91 per share. | 24 Jun 2026 | 2,854 | 5,961 | - | 311.9 | 890,203 | Common Stock |
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Sale of securities on an exchange or to another person at price $ 310.89 per share. | 24 Jun 2026 | 1,750 | 8,815 | - | 310.9 | 544,056 | Common Stock |
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Sale of securities on an exchange or to another person at price $ 314.90 per share. | 24 Jun 2026 | 1,279 | 3,174 | - | 314.9 | 402,758 | Common Stock |
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Sale of securities on an exchange or to another person at price $ 308.24 per share. | 24 Jun 2026 | 1,240 | 11,564 | - | 308.2 | 382,221 | Common Stock |
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Sale of securities on an exchange or to another person at price $ 312.83 per share. | 24 Jun 2026 | 1,004 | 4,957 | - | 312.8 | 314,081 | Common Stock |
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Sale of securities on an exchange or to another person at price $ 309.38 per share. | 24 Jun 2026 | 999 | 10,565 | - | 309.4 | 309,074 | Common Stock |
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Sale of securities on an exchange or to another person at price $ 315.70 per share. | 24 Jun 2026 | 837 | 2,337 | - | 315.7 | 264,245 | Common Stock |
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Sale of securities on an exchange or to another person at price $ 306.77 per share. | 24 Jun 2026 | 683 | 12,804 | - | 306.8 | 209,522 | Common Stock |
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Sale of securities on an exchange or to another person at price $ 313.66 per share. | 24 Jun 2026 | 504 | 4,453 | - | 313.7 | 158,086 | Common Stock |
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Sale of securities on an exchange or to another person at price $ 305.31 per share. | 24 Jun 2026 | 320 | 13,487 | - | 305.3 | 97,699 | Common Stock |
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Sale of securities on an exchange or to another person at price $ 303.12 per share. | 24 Jun 2026 | 120 | 13,807 | - | 303.1 | 36,375 | Common Stock |
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Sale of securities on an exchange or to another person at price $ 301.40 per share. | 24 Jun 2026 | 10 | 13,927 | - | 301.4 | 3,014 | Common Stock |
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 1,371 | 2,337 | - | 0 | Common Stock | |
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 648 | 648 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 10,520 | 10,520 | - | - | Stock Option (Right to Buy) | |
| Oncternal Therapeutics Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 2,200 | 2,200 | - | - | Stock Options | |
| ITeos Therapeutics Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 24,200 | 24,200 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 8,566 | 8,566 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 44,766 | 44,766 | - | - | Stock Option (Right to Buy) | |
| Oncternal Therapeutics Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 25,000 | 25,000 | - | - | Stock Options | |
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 28,981 | 28,981 | - | - | Stock Option (Right to Buy) | |
| Kinnate Biopharma Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Oncternal Therapeutics Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 50,000 | 50,000 | - | - | Stock Option | |
| Praxis Precision Medicines Inc | Jill DeSimone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 45,511 | 45,511 | - | - | Stock Option (Right to Buy) |